ResearcherBiomedical Research Center of the Slovak Academy of SciencesActive in the last 2 years
Verona Buociková
Matched on ORCID iD 0000-0002-2466-9126; OpenAlex author ID A5031699111. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 3 papers · 2026: 1 paper
Papers 7
- Epigenetic modulation to overcome immune suppression in pancreatic cancer. Co-author DOI 10.1186/s13148-026-02081-5↗
- Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biopha.2025.118428↗
- Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Co-author DOI 10.1016/j.semcancer.2025.01.003↗
- Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells as a pancreatic ductal adenocarcinoma tr… Co-author DOI 10.1186/s12935-025-04130-0↗
- Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival. Co-author DOI 10.1016/j.biopha.2023.115179↗
- Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue. Co-author DOI 10.3791/65229↗
- DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. First author DOI 10.3390/ijms23042117↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Božena Smolková · 7 shared papers, 2022–2026 · strength 1.29
- Paper Epigenetic modulation to overcome immune suppression in pancreatic cancer. DOI 10.1186/s13148-026-02081-5↗
- Paper Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. DOI 10.1016/j.semcancer.2025.01.003↗
- Paper Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells … DOI 10.1186/s12935-025-04130-0↗
- Maria Urbanova · 6 shared papers, 2022–2025 · strength 0.98
- Paper Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. DOI 10.1016/j.semcancer.2025.01.003↗
- Paper Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells … DOI 10.1186/s12935-025-04130-0↗
- Paper Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biopha.2025.118428↗
- Julie Earl · 4 shared papers, 2022–2025 · strength 0.61
- Paper Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. DOI 10.1016/j.semcancer.2025.01.003↗
- Paper Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival. DOI 10.1016/j.biopha.2023.115179↗
- Paper DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. DOI 10.3390/ijms23042117↗
- Michal Mego · 2 shared papers, 2025–2026 · strength 0.49
- Laura Drndakova · 2 shared papers, 2025–2026 · strength 0.49
- Č Altaner · 2 shared papers, 2025 · strength 0.37
- Paper Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells … DOI 10.1186/s12935-025-04130-0↗
- Paper Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biopha.2025.118428↗
- Jana Jakubechova · 2 shared papers, 2025 · strength 0.37
- Paper Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells … DOI 10.1186/s12935-025-04130-0↗
- Paper Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biopha.2025.118428↗
- Bruno Sáinz · 2 shared papers, 2023 · strength 0.28
- Chiara Corradi · 1 shared paper, 2025 · strength 0.19
- Jörg Tost · 1 shared paper, 2025 · strength 0.19
- Seçil Ak Aksoy · 1 shared paper, 2025 · strength 0.19
- Riccardo Farinella · 1 shared paper, 2025 · strength 0.19
- Ján Strnádel · 1 shared paper, 2025 · strength 0.19
- Daniele Campa · 1 shared paper, 2025 · strength 0.19
- Alena Gábelová · 1 shared paper, 2023 · strength 0.15
- Daniel Pinďák · 1 shared paper, 2023 · strength 0.15
- Sabina Strapcova · 1 shared paper, 2022 · strength 0.13
- Mária Novisedláková · 1 shared paper, 2022 · strength 0.13
- Soňa Čierniková · 1 shared paper, 2022 · strength 0.13
- Eliška Švastová · 1 shared paper, 2022 · strength 0.13
- Jesús Frutos Dıáz-Alejo · 1 shared paper, 2023 · strength 0.13
- Eduardo Lobo · 1 shared paper, 2023 · strength 0.13
- Carmen E. Guerra · 1 shared paper, 2023 · strength 0.13
- Alfredo Carrato Mena · 1 shared paper, 2023 · strength 0.13
- Carolina de la Pinta Alonso · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.